Sanofi reported Q3 2024 sales growth of 15.7%, reaching 13.4 billion euros ($14.2 billion), with EPS up 12.2% to 2.86 euros.

Sanofi  (EPA:SASY) shares rose on Friday after the pharmaceutical giant posted better-than-expected third-quarter results, ...

This week, Roche RHHBY announced its third-quarter and nine-month results. Sanofi SNY confirmed that it is holding exclusive ...

The Competition Commission of Pakistan (CCP) on Friday approved the acquisition of trademarks for the pharmaceutical product ...

Sanofi SNY reported third-quarter 2024 adjusted earnings of $1.57 per American depositary share, which beat the Zacks ...

Belgian biotech Agomab Therapeutics today announced a $89 million (82.1 million euros) Series D financing round, with ...

The focal points of the events were artificial intelligence and global market developments and innovations for air cargo and ...

Treatment MarketThe global castration-resistant prostate cancer (CRPC) treatment market is poised for substantial growth, ...

The global vaccines market is poised for extraordinary growth, with projections indicating a Compound Annual Growth Rate (CAGR) of 6.6%. This anticipated expansion will elevate the market from its ...

To celebrate Halloween and the exceptional results of their facial hair removal products, Dermrays is offering a special promotion end by October 31, 2024. Customers can enjoy $100 OFF plus receive a ...

The Wuzhen Summit of the 2024 World Internet Conference will be held in Wuzhen, Zhejiang Province, China, from November 19 to 22. On October 24, the World Internet Conference International ...

Swedish Orphan Biovitrum AB (BIOVF) reports impressive revenue growth and strategic progress, despite facing market challenges and competitive pressures.